38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study

      research-article
      1 , 1 , 2 , 2 , 3 , 3 , 4 , 5 , 6 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 1
      BMJ Open
      BMJ Publishing Group
      Epidemiology, Public Health, Statistics & Research Methods

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          To assess the extent to which stage at diagnosis and adherence to treatment guidelines may explain the persistent differences in colorectal cancer survival between the USA and Europe.

          Design

          A high-resolution study using detailed clinical data on Dukes’ stage, diagnostic procedures, treatment and follow-up, collected directly from medical records by trained abstractors under a single protocol, with standardised quality control and central statistical analysis.

          Setting and participants

          21 population-based registries in seven US states and nine European countries provided data for random samples comprising 12 523 adults (15–99 years) diagnosed with colorectal cancer during 1996–1998.

          Outcome measures

          Logistic regression models were used to compare adherence to ‘standard care’ in the USA and Europe. Net survival and excess risk of death were estimated with flexible parametric models.

          Results

          The proportion of Dukes’ A and B tumours was similar in the USA and Europe, while that of Dukes’ C was more frequent in the USA (38% vs 21%) and of Dukes’ D more frequent in Europe (22% vs 10%). Resection with curative intent was more frequent in the USA (85% vs 75%). Elderly patients (75–99 years) were 70–90% less likely to receive radiotherapy and chemotherapy. Age-standardised 5-year net survival was similar in the USA (58%) and Northern and Western Europe (54–56%) and lowest in Eastern Europe (42%). The mean excess hazard up to 5 years after diagnosis was highest in Eastern Europe, especially among elderly patients and those with Dukes’ D tumours.

          Conclusions

          The wide differences in colorectal cancer survival between Europe and the USA in the late 1990s are probably attributable to earlier stage and more extensive use of surgery and adjuvant treatment in the USA.

          Elderly patients with colorectal cancer received surgery, chemotherapy or radiotherapy less often than younger patients, despite evidence that they could also have benefited.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: not found

          EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

          EUROCARE-4 analysed about three million adult cancer cases from 82 cancer registries in 23 European countries, diagnosed in 1995-1999 and followed to December 2003. For each cancer site, the mean European area-weighted observed and relative survival at 1-, 3-, and 5-years by age and sex are presented. Country-specific 1- and 5-year relative survival is also shown, together with 5-year relative survival conditional to surviving 1-year. Within-country variation in survival is analysed for selected cancers. Survival for most solid cancers, whose prognosis depends largely on stage at diagnosis (breast, colorectum, stomach, skin melanoma), was highest in Finland, Sweden, Norway and Iceland, lower in the UK and Denmark, and lowest in the Czech Republic, Poland and Slovenia. France, Switzerland and Italy generally had high survival, slightly below that in the northern countries. There were between-region differences in the survival for haematologic malignancies, possibly due to differences in the availability of effective treatments. Survival of elderly patients was low probably due to advanced stage at diagnosis, comorbidities, difficult access or lack of availability of appropriate care. For all cancers, 5-year survival conditional to surviving 1-year was higher and varied less with region, than the overall relative survival.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

            Adjuvant chemotherapy is standard treatment for patients with resected colon cancer who are at high risk for recurrence, but the efficacy and toxicity of such treatment in patients more than 70 years of age are controversial. We performed a pooled analysis, based on the intention to treat, of individual patient data from seven phase 3 randomized trials (involving 3351 patients) in which the effects of postoperative fluorouracil plus leucovorin (five trials) or fluorouracil plus levamisole (two trials) were compared with the effects of surgery alone in patients with stage II or III colon cancer. The patients were grouped into four age categories of equal size, and analyses were repeated with 10-year age ranges ( 70 years), with the same conclusions. The toxic effects measured in all trials were nausea or vomiting, diarrhea, stomatitis, and leukopenia. Patients in the fluorouracil-plus-leucovorin and fluorouracil-plus-levamisole groups were combined for the efficacy analysis but kept separate for toxicity analyses. Adjuvant treatment had a significant positive effect on both overall survival and time to tumor recurrence (P 70 years), except for leukopenia in one study. Selected elderly patients with colon cancer can receive the same benefit from fluorouracil-based adjuvant therapy as their younger counterparts, without a significant increase in toxic effects.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer.

              WH Hall (1990)
                Bookmark

                Author and article information

                Journal
                BMJ Open
                BMJ Open
                bmjopen
                bmjopen
                BMJ Open
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2044-6055
                2013
                10 September 2013
                : 3
                : 9
                : e003055
                Affiliations
                [1 ]Cancer Research UK Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine , London, UK
                [2 ]Division of Cancer Prevention and Control, Centers for Disease Control and Prevention , Atlanta, Georgia, USA
                [3 ]Côte-d'Or Digestive Cancer Registry, Faculté de Médecine , Dijon Cédex, France
                [4 ]Evaluative Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan, Italy
                [5 ]National Center of Epidemiology, Surveillance and Promotion of Health, National Institute of Health , Rome, Italy
                [6 ]Descriptive Studies and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan, Italy
                [7 ]Alleanza Contro il Cancro , Rome, Italy
                [8 ]Department of Epidemiology and Biostatistics, National Institute for Health Development , Tallinn, Estonia
                [9 ]Navarra Cancer Registry, Navarra Public Health Institute , Navarra, Spain
                [10 ]CIBER Epidemiology and Public Health CIBERESP , Madrid, Spain
                [11 ]National Institute of Public Health, National Institute of Hygiene , Warszawa, Poland
                [12 ]SC Department of Health and Environmental Control, South Carolina Central Cancer Registry, Office of Public Health Statistics and Information Systems , Columbia, South Carolina, USA
                [13 ]Public Health Institute, Cancer Registry of Greater California , Sacramento, California, USA
                [14 ]Comprehensive Cancer Centre the Netherlands , Utrecht, The Netherlands
                [15 ]Rhode Island Department of Health, Rhode Island Cancer Registry , Providence, Rhode Island, USA
                [16 ]Tarragona Cancer Registry, Foundation Society for Cancer Research and Prevention, Pere Virgili Health Research Institute , Tarragona, Spain
                [17 ]Świeętokrzyskie Centrum Onkologii (Holycross Cancer Centre) , Kielce, Poland
                [18 ]Faculty of Health Sciences, Jan Kochanowski University of Humanities and Sciences in Kielce , Kielce, Poland
                [19 ]Finnish Cancer Registry, Helsinki, Finland
                [20 ]Epidemiology and Cancer Registry, Institute of Oncology Ljubljana , Ljubljana, Slovenia
                [21 ]Cracow Cancer Registry, Centre of Oncology, M Skłodowska-Curie Memorial Cancer Institute , Krakow, Poland
                [22 ]National Cancer Registry of Slovakia, National Health Information Center , Bratislava, Slovakia
                [23 ]Andalusian School of Public Health , Granada, Spain
                [24 ]CIBER Epidemiología y Salud Pública (CIBERESP) , Madrid, Spain
                [25 ]New York State Department of Health, New York State Cancer Registry , Albany, New York, USA
                [26 ]Illinois Department of Public Health, Illinois State Cancer Registry , Springfield, Illinois, USA
                [27 ]Cancer Registry and Environmental Epidemiology Division, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan, Italy
                [28 ]Cancer Registry and Histopathology Unit, Civile-MP Arezzo Hospital, ASP Ragusa , Ragusa, Italy
                [29 ]UOS Epidemiologia Descrittiva, USM-IST (IRCCS Azienda Ospedaliera Universitaria San Martino—IST Istituto Nazionale per la Ricerca sul Cancro), Largo R Benzi , Genova, Italy
                [30 ]Sez. Epidemiologia Descrittiva, Dipartimento di Scienze della Salute, Università di Genova , Genova, Italy
                [31 ]Cancer Prevention and Control Division, University of Colorado Cancer Center, Colorado School of Public Health , Aurora, Colorado, USA
                [32 ]Louisiana Tumor Registry, LSU Health Sciences Center School of Public Health , New Orleans, Louisiana, USA
                Author notes
                [Correspondence to ] Dr Claudia Allemani; claudia.allemani@ 123456lshtm.ac.uk
                Article
                bmjopen-2013-003055
                10.1136/bmjopen-2013-003055
                3773629
                24022388
                7e7ec116-f353-4611-b16d-201fc841f51b
                Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

                This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/

                History
                : 15 April 2013
                : 26 June 2013
                : 28 June 2013
                Categories
                Epidemiology
                Research
                1506
                1692
                1724
                1695
                1717

                Medicine
                epidemiology,public health,statistics & research methods
                Medicine
                epidemiology, public health, statistics & research methods

                Comments

                Comment on this article